000566 海南海药
已收盘 10-12 15:00:00
资讯
新帖
简况
海南海药（000566）10月9日主力资金净买入890.45万元
证券之星 · 10-12 09:10
海南海药（000566）10月9日主力资金净买入890.45万元
股市必读：海南海药新发布《关于子公司获得注射用硫酸艾沙康唑药品注册批件的公告》
证券之星 · 10-12 02:16
股市必读：海南海药新发布《关于子公司获得注射用硫酸艾沙康唑药品注册批件的公告》
海南海药最新公告：子公司获注射用硫酸艾沙康唑药品注册批件
证券之星 · 10-09
海南海药最新公告：子公司获注射用硫酸艾沙康唑药品注册批件
海南海药（000566）9月23日主力资金净卖出2017.26万元
证券之星 · 09-24
海南海药（000566）9月23日主力资金净卖出2017.26万元
异动快报：海南海药（000566）9月21日10点54分触及涨停板
证券之星 · 09-21
异动快报：海南海药（000566）9月21日10点54分触及涨停板
海南海药最新公告：销售代理合同纠纷案原告撤诉
证券之星 · 09-16
海南海药最新公告：销售代理合同纠纷案原告撤诉
海南海药：氟非尼酮胶囊正在开展III期临床研究
证券之星 · 09-11
海南海药：氟非尼酮胶囊正在开展III期临床研究
海南海药：紧盯创新药核心突破
证券之星 · 09-11
海南海药：紧盯创新药核心突破
海南海药：符合资本化条件的研发项目按会计准则资本化
证券之星 · 09-11
海南海药：符合资本化条件的研发项目按会计准则资本化
海南海药：晏小敏先生于2026年8月27日担任公司董事会秘书一职
证券之星 · 09-11
海南海药：晏小敏先生于2026年8月27日担任公司董事会秘书一职
海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%
证券之星 · 08-31
海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%
海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显
证券之星 · 08-30
海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显
海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%
证券之星 · 08-29
海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%
图解海南海药中报：第二季度单季净利润同比下降50.80%
证券之星 · 08-29
图解海南海药中报：第二季度单季净利润同比下降50.80%
股市必读：海南海药（000566）8月21日董秘有最新回复
证券之星 · 08-24
股市必读：海南海药（000566）8月21日董秘有最新回复
海南海药：解决同业竞争事关公司规范治理与长远未来
证券之星 · 08-21
海南海药：解决同业竞争事关公司规范治理与长远未来
海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进
证券之星 · 08-21
海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进
海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%
证券之星 · 08-14
海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%
7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元
证券之星 · 07-31
7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元
异动快报：海南海药（000566）7月30日9点54分触及涨停板
证券之星 · 07-30
异动快报：海南海药（000566）7月30日9点54分触及涨停板
加载更多
公司概况
公司名称：
海南海药股份有限公司
所属行业：
医药制造业
上市日期：
1994-05-25
主营业务：
海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列。
发行价格：
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":4.5,"timestamp":1791788634000,"preClose":4.71,"halted":0,"volume":55211173,"delay":0,"changeRate":-0.0446,"floatShares":1297000000,"shares":1297000000,"eps":-0.3729,"marketStatus":"已收盘","change":-0.21,"latestTime":"10-12 15:00:00","open":4.68,"high":4.72,"low":4.48,"amount":251000000,"amplitude":0.051,"askPrice":4.51,"askSize":1097,"bidPrice":4.5,"bidSize":4476,"shortable":0,"etf":0,"ttmEps":-0.3729,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.71,"symbolType":"stock","openAndCloseTimeList":[[1791768600000,1791775800000],[1791781200000,1791788400000]],"highLimit":5.18,"lowLimit":4.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"isCdr":false,"pbRate":-46.35,"roa":"--","roe":"0.0%","epsLYR":-0.3314,"committee":0.490838,"marketValue":5838000000,"turnoverRate":0.0426,"status":1,"floatMarketCap":5835000000},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2674847513","title":"海南海药（000566）10月9日主力资金净买入890.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674847513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674847513?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:10","pubTimestamp":1791767427,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，海南海药报收于4.71元，上涨3.97%，换手率6.56%，成交量85.0万手，成交额3.9亿元。近5日资金流向一览见下表：海南海药融资融券信息显示，融资方面，当日融资买入937.1万元，融资偿还1174.71万元，融资净偿还237.61万元。海南海药主营业务：围绕大健康布局,涵盖中间体、原料药、化学制剂、现代中药及医疗服务等领域,目前以药品研发、生产和销售为主。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200002966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000566","BK0239","BK0070","BK0060","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674845953","title":"股市必读：海南海药新发布《关于子公司获得注射用硫酸艾沙康唑药品注册批件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674845953","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674845953?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:16","pubTimestamp":1791742571,"startTime":"0","endTime":"0","summary":"公司公告汇总关于子公司获得注射用硫酸艾沙康唑药品注册批件的公告近日，海南海药股份有限公司全资子公司海口市制药厂有限公司获得国家药品监督管理局核准签发的化学药品“注射用硫酸艾沙康唑”的《药品注册证书》。该药品适用于治疗成人和1岁及以上儿童患者的侵袭性曲霉病、侵袭性毛霉病。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","000566","BK0188","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851121","title":"海南海药最新公告：子公司获注射用硫酸艾沙康唑药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851121","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674851121?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:17","pubTimestamp":1791548273,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，公司全资子公司海口市制药厂获国家药监局核准签发的注射用硫酸艾沙康唑《药品注册证书》。该药品适用于治疗成人和1岁及以上儿童患者的侵袭性曲霉病、侵袭性毛霉病。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900034417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","000566","BK0060","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430282","title":"海南海药（000566）9月23日主力资金净卖出2017.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430282?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:17","pubTimestamp":1790212658,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，海南海药报收于4.8元，下跌3.61%，换手率6.21%，成交量80.58万手，成交额3.92亿元。近5日资金流向一览见下表：海南海药融资融券信息显示，融资方面，当日融资买入1388.92万元，融资偿还1390.78万元，融资净偿还1.86万元。海南海药主营业务：围绕大健康布局,涵盖中间体、原料药、化学制剂、现代中药及医疗服务等领域,目前以药品研发、生产和销售为主。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0146","000566","BK0070","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316191","title":"异动快报：海南海药（000566）9月21日10点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669316191?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:55","pubTimestamp":1789959326,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，10点54分海南海药（000566）触及涨停板。其所属行业化学制药目前上涨。领涨股为华仁药业。该股为创新药，CAR-T疗法，医药概念热股，当日创新药概念上涨4.55%，CAR-T疗法概念上涨4.18%，医药概念上涨3.9%。9月18日的资金流向数据方面，主力资金净流出1504.86万元，占总成交额6.65%，游资资金净流入791.97万元，占总成交额3.5%，散户资金净流入712.89万元，占总成交额3.15%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100007626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0060","BK0188","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667365986","title":"海南海药最新公告：销售代理合同纠纷案原告撤诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2667365986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667365986?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:10","pubTimestamp":1789564253,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，公司收到海口市秀英区人民法院《民事裁定书》，原告陈光华、文瑞就销售代理合同纠纷案提出撤诉申请，法院裁定准许撤诉。该诉讼案件已了结，不会对公司本期利润或期后利润产生重大影响。截至公告披露日，公司尚未结案的诉讼、仲裁案件涉及金额总计约1.16亿元，占最近一期经审计净资产的97.04%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0146","000566","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666226025","title":"海南海药：氟非尼酮胶囊正在开展III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2666226025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666226025?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:52","pubTimestamp":1789131135,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问至8月30日，股东人数多少？两款创新药进展如何？氟非尼酮三期入组了吗海南海药回复：尊敬的投资者您好！公司根据规定在定期报告中披露相关股东人数，敬请查阅已经披露的定期报告并关注后续披露的定期报告。派恩加滨片正在开展IIb期临床研究。氟非尼酮胶囊正在开展III期临床研究，入组情况请关注CDE药物临床试验登记与信息公示平台的信息。公司如有达到信息披露标准的新进展，将根据规定及时履行信息披露义务。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100047601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000566","BK0070","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522670","title":"海南海药：紧盯创新药核心突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666522670?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:52","pubTimestamp":1789131125,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，贵公司半年报后净资产已经为负，营收连年下滑，扣非9年亏损，生存困难。氟非尼酮目前进入关键III期验证，派恩加滨IIB期，HY-001临床前期。创新药烧钱，贵公司资金短缺，为何不砍掉或者出售创新药管线，全力保壳？本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100047590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1574","BK0146","06978","000566","BK0060","BK0070","BK1161","BK0239","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522962","title":"海南海药：符合资本化条件的研发项目按会计准则资本化","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666522962?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:52","pubTimestamp":1789131124,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，派恩加滨IIB期伦理会已于8月7日由首都医科大学附属北京天坛医院医学伦理委员会批准过会，CDE已经公示IIB期方案，请问IIB期的研发投入是否可以资本化处理？海南海药回复：尊敬的投资者您好！公司对于符合资本化条件的研发项目，根据会计准则要求进行资本化处理，资本化投入不影响当期损益。具体情况请以公司定期报告及公开披露信息为准。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100047587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","000566","BK0060","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666229645","title":"海南海药：晏小敏先生于2026年8月27日担任公司董事会秘书一职","url":"https://stock-news.laohu8.com/highlight/detail?id=2666229645","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666229645?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:52","pubTimestamp":1789131124,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，董事长！原则上董事长代董秘履职不超过三个月，目前已经接近三个月了，请问贵公司新任董秘有何消息？海南海药回复：尊敬的投资者您好！晏小敏先生于2026年8月27日担任公司董事会秘书一职。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100047586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0060","BK0188","BK0146","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071812","title":"海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071812","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071812?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:48","pubTimestamp":1788169703,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，海南海药报收于4.95元，较前一交易日下跌1.79%，最新总市值为64.22亿元。近日，海南海药股份有限公司披露《2026年半年度报告》。报告期末普通股股东总数为126,648户。公司控股股东及实际控制人在报告期内未发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000566","BK0146","BK0188","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663246048","title":"海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663246048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663246048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:20","pubTimestamp":1788042022,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海南海药发布2026年中报。截至本报告期末，公司营业总收入3.21亿元，同比下降28.65%，归母净利润-2.12亿元，同比下降33.97%。本报告期海南海药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达44.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012608","title":"海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012608","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012608?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:12","pubTimestamp":1787994732,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海南海药披露，截至2026年6月30日公司股东户数为12.66万户，较3月31日增加1.38万户，增幅为12.22%。在化学制药行业个股中，海南海药股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，海南海药区间跌幅为8.27%，在此期间股东户数增加1.38万户，增幅为12.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","000566","BK0060","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018461","title":"图解海南海药中报：第二季度单季净利润同比下降50.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018461","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663018461?lang=zh_cn&edition=full","pubTime":"2026-08-29 02:31","pubTimestamp":1787941919,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药2026年中报显示，上半年度公司主营收入3.21亿元，同比下降28.65%；归母净利润-2.12亿元，同比下降33.97%；扣非净利润-2.52亿元，同比下降39.73%；其中2026年第二季度，公司单季度主营收入1.53亿元，同比下降37.18%；单季度归母净利润-1.36亿元，同比下降50.8%；单季度扣非净利润-1.51亿元，同比下降48.29%；负债率101.87%，投资收益-449.33万元，财务费用8468.32万元，毛利率18.24%。财报数据概要请见下图:本文数据来源于海南海药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900006109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243784","title":"股市必读：海南海药（000566）8月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661243784?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:04","pubTimestamp":1787504652,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，海南海药报收于4.84元，下跌6.56%，换手率8.82%，成交量114.37万手，成交额5.53亿元。当日关注点交易信息汇总：8月21日主力资金净流出3587.67万元，占总成交额6.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0146","BK0070","BK0060","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298732","title":"海南海药：解决同业竞争事关公司规范治理与长远未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661298732?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:52","pubTimestamp":1787316743,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药08月21日在投资者关系平台上答复投资者关心的问题。公司将全力加快事项推进解决，以实实在在的行动推进各项工作，维护股东长远利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100043011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0060","BK0070","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661987632","title":"海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2661987632","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661987632?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:52","pubTimestamp":1787316739,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，董事长及海药管理层，贵公司创新药进展一直为业内所诟病，进度缓慢？请问管理层对于创新药进展有没有督促管理方案？海南海药回复：您好，公司紧盯创新药核心突破，持续加码两款创新药研发投入，全速推进临床试验进程，氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进。公司将根据进展情况及时履行信息披露义务，敬请广大投资者注意投资风险。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100043006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","000566","BK0060","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659800147","title":"海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659800147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659800147?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:06","pubTimestamp":1786716399,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，海南海药报收于5.45元，较前一交易日下跌4.22%，最新总市值为70.71亿元。该股当日开盘5.62元，最高5.73元，最低5.36元，成交额达8.69亿元，换手率为12.22%。近日，海南海药股份有限公司及全资子公司海口市制药厂有限公司作为被告，收到海口市秀英区人民法院送达的《应诉通知书》。法院已受理，尚未开庭审理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400039618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","BK0146","000566","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655354288","title":"7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655354288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655354288?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:40","pubTimestamp":1785490857,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月31日公布的交易公开信息显示，海南海药因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月31日收盘，海南海药报收于5.86元，下跌1.51%，换手率25.55%，成交量331.33万手，成交额19.11亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入6771.65万元，北向资金合计净买入1954.0万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100029714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000566","BK0239","BK0070","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655849858","title":"异动快报：海南海药（000566）7月30日9点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2655849858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655849858?lang=zh_cn&edition=full","pubTime":"2026-07-30 10:01","pubTimestamp":1785376891,"startTime":"0","endTime":"0","summary":"证券之星7月30日盘中消息，9点54分海南海药（000566）触及涨停板。其所属行业化学制药目前上涨。领涨股为海南海药。该股为海南自由贸易港，海南概念，自由贸易港概念热股，当日海南自由贸易港概念上涨2.58%，海南概念概念上涨2.21%，自由贸易港概念上涨2.03%。7月29日的资金流向数据方面，主力资金净流出869.69万元，占总成交额0.62%，游资资金净流出9693.1万元，占总成交额6.92%，散户资金净流入1.06亿元，占总成交额7.54%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000009435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","BK0146","000566","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791831620415,"stockEarnings":[{"period":"1week","weight":-0.026},{"period":"1month","weight":-0.0385},{"period":"3month","weight":-0.0385},{"period":"6month","weight":-0.1773},{"period":"1year","weight":-0.1758},{"period":"ytd","weight":-0.3706}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南海药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"126648人(较上一季度增加12.22%)","perCapita":"10238股","listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","registeredCapital":"129736万元","survey":" 海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列。","listedPrice":5.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}